Tri-Coast Pharmacy is recalling 17 vials of TriMix (Alprostadil/Phentolamine/Papaverine), a compounded injectable medication, that were produced between May 17, 2016, and November 17, 2016. The recall was initiated because the pharmacy cannot guarantee the sterility of these specific batches. Consumers should check their medication for lot codes 07282016G, 07082016E, or 07142016D.
A lack of sterility assurance in an injectable medication poses a significant risk of localized or systemic infection, as contaminants may have been introduced during the compounding process. No specific injuries have been reported, but the risk remains medium due to the invasive nature of the drug's administration.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.